Friday, July 17, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

D-Wave Quantum’s 52% Surge Puts Nvidia and Commercial Contracts in the Spotlight

Kennethcix by Kennethcix
April 23, 2026
in AI & Quantum Computing, Nasdaq, Tech & Software, Trading & Momentum
0
D-Wave Quantum Stock
0
SHARES
29
VIEWS
Share on FacebookShare on Twitter

A seismic shift from Nvidia has sent shockwaves through the quantum computing sector, with D-Wave Quantum Inc. riding the crest of the wave. The company’s shares soared 52% in a single week, briefly seeing its trading volume on April 20, 2026, eclipse that of every other U.S. stock. This explosive move, however, is colliding with a stark reality: a valuation demanding proof that recent multi-million dollar contracts can justify the hype.

The catalyst was Nvidia’s April 14 announcement of its Ising model family, billed as the world’s first open-source AI family for quantum computing. The two models, Ising Calibration and Ising Decoding, promise to correct errors in quantum computer outputs up to three times faster than existing methods. CEO Jensen Huang framed the move as critical for the technology’s commercial viability. For investors, it was a green light. Institutional ownership of D-Wave jumped to 42.47%, and trading volume on the announcement day hit 90.2 million shares—roughly 227% above the three-month average.

D-Wave’s leadership was quick to leverage the spotlight. At the Semafor World Economy Summit, CEO Alan Baratz issued a direct challenge. “If I were Nvidia, I’d be shaking in my boots,” he stated, contrasting his company’s systems, which he says consume about 10 kilowatts, against the energy-hungry data centers required for traditional high-performance computing. Baratz argued D-Wave has already had its “ChatGPT moment,” solving commercially valuable problems that are intractable for classical computers.

The rally finds some footing in tangible commercial progress. The company reported a 179% revenue surge to $24.6 million for 2025. More critically, bookings for the first quarter of 2026 already stand at $32.8 million. This figure is bolstered by a $20 million system sale to the Florida Atlantic University and a significant, newly revealed two-year, $10 million Quantum Computing-as-a-Service (QCaaS) contract with an unnamed Fortune 100 company. Established clients like Volkswagen and Lockheed Martin are already using D-Wave’s technology in operational settings for supply chain and personnel planning.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

A key part of D-Wave’s growth strategy is technological expansion via acquisition. The January purchase of Quantum Circuits for $250 million in cash plus 10.43 million new shares adds gate-model technology to complement D-Wave’s established annealing systems, with the first product expected later this year.

Wall Street’s view is polarized. Analysts like Wedbush’s Antoine Legault maintain an Outperform rating, citing over 135 customers and strong booking growth. The options market also reflects bullish sentiment, with call buying outpacing put activity. Yet caution flags are flying. Canaccord analyst Kingsley Crane, while acknowledging a strong pipeline, highlights the stock’s extreme valuation at 150 times expected 2027 revenue, framing it as a high-risk concept investment.

All eyes now turn to the upcoming quarterly earnings. The results will serve as the first major test of whether the recent booking dynamism can successfully convert into recognized revenue, providing the fundamental support needed for its newly elevated, and fiercely debated, market price.

Ad

D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from July 17 delivers the answer:

The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 17.

D-Wave Quantum: Buy or sell? Read more here...

Tags: D-Wave Quantum
Kennethcix

Kennethcix

Related Posts

Applovin Stock
Analysis

AppLovin’s Insider Exodus and Pixel Slowdown Raise Questions Ahead of Earnings

July 17, 2026
Lang & Schwarz Stock
Banking & Insurance

Lang & Schwarz Trades Below Book Value as It Unveils €30m Structured Products Profit and €2 Dividend

July 17, 2026
Micron Stock
AI & Quantum Computing

Behind Micron’s 25% Rout: A Fully Booked HBM Pipeline and $25 Billion in New Factories

July 17, 2026
Next Post
Lynas Rare Earths Stock

Lynas Rare Earths: A High-Stakes Balancing Act

Lufthansa Stock

Lufthansa Navigates Fuel Crisis as Key Shareholder Meeting Looms

Volkswagen Stock

Volkswagen's Strategic Tightrope: Cutting Capacity While Doubling Down in China

Recommended

Unitedhealth Stock

Could Warren Buffett’s Investment Signal a Turnaround for UnitedHealth?

11 months ago
Amazon Stock

Amazon’s AI Ambitions Offset by Logistics Headwinds

4 months ago
Commerzbank Stock

Commerzbank’s Standalone Strategy Intensifies as BaFin Clamps Down on UniCredit

3 months ago
TKMS Stock

TKMS: A Naval Giant’s Fate Hinges on Three Critical Weeks

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

AppLovin’s Insider Exodus and Pixel Slowdown Raise Questions Ahead of Earnings

Pentixapharm’s Busy Week: FDA Fast-Track, Rights Offering, and a BaFin Review All in Play

Lang & Schwarz Trades Below Book Value as It Unveils €30m Structured Products Profit and €2 Dividend

Behind Micron’s 25% Rout: A Fully Booked HBM Pipeline and $25 Billion in New Factories

SanDisk’s Plunge Meets a Wall of Institutional Buying as Analysts Split on AI Demand

From Cost Center to Cloud: Meta’s Infrastructure Avalanche Meets a Skeptical Analyst

Trending

ABB Stock
European Markets

Record Orders and a Pricy Takeover: ABB Stakes Its Future on Rotork and a Robotics Exit

by Rodolfo Hanigan
July 17, 2026
0

ABB is in the midst of a sweeping portfolio overhaul that few investors expected to come at...

Allianz Stock

Allianz Defies Jefferies’ Stubborn €325 Target as Buyback Hits €1.5B and Bullish Calls Multiply

July 17, 2026
Caterpillar Stock

Caterpillar’s Two-Speed Engine: Record Backlog Masks Cyclical Headwinds

July 17, 2026
Applovin Stock

AppLovin’s Insider Exodus and Pixel Slowdown Raise Questions Ahead of Earnings

July 17, 2026
Pentixapharm Stock

Pentixapharm’s Busy Week: FDA Fast-Track, Rights Offering, and a BaFin Review All in Play

July 17, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Record Orders and a Pricy Takeover: ABB Stakes Its Future on Rotork and a Robotics Exit
  • Allianz Defies Jefferies’ Stubborn €325 Target as Buyback Hits €1.5B and Bullish Calls Multiply
  • Caterpillar’s Two-Speed Engine: Record Backlog Masks Cyclical Headwinds

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com